期刊
NATURE REVIEWS UROLOGY
卷 17, 期 2, 页码 119-130出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41585-019-0274-3
关键词
-
资金
- Cancer Council, New South Wales, Australia
- National Health and Medical Research Council (NHMRC), Australia
Prostate cancer progression has been shown to be dependent on the development of autonomic nerves into the tumour microenvironment. Sympathetic nerves activate adrenergic neurosignalling that is necessary in early stages of tumour progression and for initiating an angiogenic switch, whereas parasympathetic nerves activate cholinergic neurosignalling resulting in tumour dissemination and metastasis. The innervation of prostate cancer seems to be initiated by neurotrophic growth factors, such as the precursor to nerve growth factor secreted by tumour cells, and the contribution of brain-derived neural progenitor cells has also been reported. Current experimental, epidemiological and clinical evidence shows the stimulatory effect of tumour innervation and neurosignalling in prostate cancer. Using nerves and neurosignalling could have value in the management of prostate cancer by predicting aggressive disease, treating localized disease through denervation and relieving cancer-associated pain in bone metastases. In this Review, the authors describe the current evidence showing the stimulatory effect of tumour innervation and neurosignalling in prostate cancer. They discuss the clinical and epidemiological evidence and the potential of using nerves and neurosignalling for diagnosis, prognosis and treatment of prostate cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据